Page 1216 - Cote clinical veterinary advisor dogs and cats 4th
P. 1216

606   Lymphoma, Gastrointestinal


           •  Managing  anemia  with  transfusions  and   ○   Because of the high likelihood of systemic   •  Anatomic  location  may  have  prognostic
            hematinics as needed (p. 1169)        or local spread, these animals are followed   significance  for  dogs.  Colonic  lymphoma
  VetBooks.ir  •  Analgesics as indicated for pain  •  Cobalamin  supplementation  as  needed     •  Cats with low-grade GI LSA require minimal
                                                  with a course of chemotherapy.
                                                                                   is associated with a better prognosis than
           •  Antibiotics and emergency management for
                                                                                   gastric or jejunal lymphoma.
            peritonitis (p. 779)
                                                (p. 183)
           •  Promotility  agents  are  contraindicated  in
            obstructive disease.              Nutrition/Diet                       therapy and may survive for years using treat-
                                                                                   ment with chlorambucil, prednisolone, and
           •  Management  of  hypercalcemia  of  malig-  These animals are often thin; efforts should be   cobalamin repletion.
            nancy (pp. 491 and 754) by IV fluids and   made to provide adequate nutritional support.   •  Antibiotic therapy (e.g., tylosin) for second-
            furosemide 1-2 mg/kg IV or PO q 12-24h   Appetite often improves if disease can be placed   ary dysbiosis may be helpful.
            after rehydration, bisphosphonates (e.g.,   in remission.
            pamidronate, zoledronate), or possibly                                PEARLS & CONSIDERATIONS
            calcitonin 4-8 IU/kg IV, IM, or SQ q 12h   Possible Complications
            acutely. Management of hypercalcemia by   •  Surgical wound dehiscence with secondary   Comments
            treating the underlying malignancy should   peritonitis, pneumoperitoneum  •  Full-thickness  surgical  biopsies  may  be
            be started only after the cytologic or histo-  •  Chemotherapy-induced neutropenia can pre-  necessary to diagnose small-intestinal LSA
            pathologic diagnosis of GI LSA is established   dispose to infection, and thrombocytopenia   because endoscopic access is limited to the
            because treatment with glucocorticoids or   can increase risk of hemorrhage.  duodenum or ileum.
            other lympholytic agents can compromise   •  Chemotherapy can result in perforation of   •  Fine-needle  aspiration  cytology  of  the
            detection of lymphoma.              transmural lesions.                intestinal wall is possible, but low-grade
                                                                                   LSA is difficult to differentiate from reactive
           Chronic Treatment                  Recommended Monitoring               lymphocyte expansion.
           •  Chemotherapy is generally the treatment of   •  CBC for chemotherapy-induced myelosup-  •  In general, the underlying cause of refrac-
            choice for GI LSA. A number of chemo-  pression                        tory diarrhea should be pursued aggressively
            therapy protocols (pp. 607 and 609) have   •  Ultrasonography is most practical for detect-  because GI LSA is an important differential
            been used to treat GI LSA.          ing intraabdominal metastasis or recurrence   diagnosis.
           •  For  high-grade  disease,  the  University  of   and may identify small amounts of peritoneal   •  Treatment with glucocorticoids may impede
            Madison-Wisconsin or similar CHOP-based   fluid as the first manifestation of peritonitis   the  accurate  diagnosis  of  LSA  because
            (cyclophosphamide, doxorubicin, vincristine,   in cases of bowel rupture.  lymphoblasts are rapidly lysed.
            prednisone/prednisolone) protocols involve  •  Periodic restaging (physical exam monthly,
            ○   Sequential treatment with CHOP drugs   laboratory evaluation, thoracic radiographs,   Prevention
              ± L-asparaginase over 19-25 weeks  abdominal  ultrasound  exam  every  other   •  Aggressive management of lymphoplasma-
            ○   Single-agent doxorubicin, mitoxantrone,   month) for patients in complete remission   cytic enteritis is recommended. IBD may
              ifosfamide, or lomustine and combination   after surgical excision or completion of dose-  progress to GI LSA.
              therapy with doxorubicin/dacarbazine   intense therapy with CHOP-based protocols.  •  Limiting exposure to lawn and agricultural
              have been used as rescue agents.                                     chemicals and second-hand smoke is likely
           •  For  low-grade  disease,  treatment  with    PROGNOSIS & OUTCOME     beneficial, but no specific preventive measures
            milder chemotherapy protocols is helpful in                            are known.
            prolonging life with good quality. Low-grade   •  GI LSA is a serious, life-threatening illness,
            protocols include                   but because of the widely different biological   Technician Tips
                                      2
            ○   Chlorambucil (commonly 20 mg/m  PO q   behaviors of various subtypes, predicting   These patients are very ill. Monitor for signs
              14 days [p. 609] or 2 mg PO q 48h) and   therapeutic response and duration of survival   of hypotension and abdominal effusion that
              prednisolone (various dosing schemes but   is difficult for individual animals.  might indicate GI perforation.
              often starting with 1-2 mg/kg PO q 24h   •  In  general,  low-grade  disease  is  indolent
              for 7-14 days, then reducing to 0.5-1 mg/  and associated with longer survival than   Client Education
              kg PO q 48h), or COP (cyclophospha-  high-grade disease, depending on extent of   Response to initial therapy can be the best
              mide, vincristine, and prednisolone)  disease at the time of diagnosis.  prognostic indicator.
           •  One study suggests lomustine as a rescue agent   •  T-cell  phenotype  is  generally  less  respon-
            for cats with resistant small or intermediate   sive and associated with shorter survival   SUGGESTED READING
            cell GI LSA achieves a longer progression-free   duration than B-cell disease. Historically,   WSAVA International Gastrointestinal Standardiza-
            interval than for large cell GI LSA.  median survival times for extranodal T-cell   tion Group: ACVIM consensus statement: endo-
           •  Abdominal  radiation  therapy  as  a  rescue   lymphomas were typically 6 months or less    scopic, biopsy, and histopathologic guidelines for
            protocol for feline GI LSA appears to be well   in dogs.               the evaluation of gastrointestinal inflammation in
            tolerated and may increase median survival   •  Treatment  efficacy  remains  variable,  with   companion animals. J Vet Intern Med 24:10, 2010.
            time.                               reported median remission times of 3-12   AUTHOR: Barbara E. Kitchell, DVM, PhD, DACVIM
            ○   Abdominal irradiation may be incorpo-  months.                   EDITOR: Rance K. Sellon DVM, PhD, DACVIM
              rated  into  the  induction  protocol.  This   •  Failure  to  achieve  remission  and  diarrhea
              is particularly helpful for cats that resist   at presentation are negative prognostic
              oral medication.                  indicators.
           •  Curative therapy for focal GI LSA lesions
            is through complete surgical excision.










                                                     www.ExpertConsult.com
   1211   1212   1213   1214   1215   1216   1217   1218   1219   1220   1221